A novel RARβ isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells

Cancer Research

Volumn 64, Issue 24, 2004, Pages 8911-8918

  Peng, Xinjian ^a   Maruo, Takeshi ^c   Cao, Yanxia ^b   Punj, Vasu ^a   Mehta, Rajeshwari ^a   Das Gupta, Tapas K ^a   Christov, Konstantin ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; ISOPROTEIN; METHIONINE; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR BETA 2; RETINOIC ACID RECEPTOR BETA 5; RETINOID X RECEPTOR; UNCLASSIFIED DRUG; MESSENGER RNA; RETINOIC ACID RECEPTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; EPITHELIUM CELL; GENE MAPPING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN TARGETING; START CODON; TUMOR SUPPRESSOR GENE; AMINO ACID SEQUENCE; BIOSYNTHESIS; BREAST; BREAST TUMOR; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PRECANCER; TUMOR CELL LINE;

AMINO ACID SEQUENCE; BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; CLONING, MOLECULAR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; PRECANCEROUS CONDITIONS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TRETINOIN;

EID: 10844253152     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1810     Document Type: Article

References (36)

1. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 1994;15:61-79.
2. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 1996;10:940-54.
3. Gudas LJ, Sporn MB, Roberts AB. Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids. 2nd ed. New York: Raven Press; 1994. p. 443-520.
4. Durand B, Saunders M, Leroy P, Leid M, Chambon P. All-trans and 9-cis retinoic acid induction of CRABPII transcription is mediated by RAR-RXR heterodimers bound to DR1 and DR2 repeated motifs. Cell 1992;71:73-85.
5. Zhang XK, Lehmann J, Hoffmann B, et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature (Lond) 1992;358:581-91.
6. Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991;65:1255-66.
7. Chen LI, Sommer K, Swisshelm K. Downstream codons in the retinoic acid recepor β-2 and β-4 mRNAs initiate translation of a protein isofom that disrupts retinoid-activated transcription. J Biol Chem 2002;277:35411-21.
8. de The H, Marchio A, Tiollais P, Dejean A. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. Nature (Lond) 1987;330:667-70.
9. de The H, Vivanco-Ruiz MDM, Tiollais P. Identification of a retinoic acid response element in the retinoic acid receptor β gene. Nature (Lond) 1990;343:177-80.
10. Nagpal S, Zelent A, Chambon P. RAR-β4, a retinoic acid receptor isoform is generated from RAR-β2 by alternative splicing and usage of a CUG initiator codon. Proc Nat Acad Sci USA 1992;89:27118-22.
11. Sommer KM, Chen LI, Treuting PM, Smith LT, Swisshelm K. Elevated retinoic acid receptor β4 protein in human breast tumor cells with nuclear and cytoplasmic localization. Proc Natl Acad Sci USA 1999;96:8651-6.
12. Houle B, Pelletier M, Wu J, Gooddyer C, Bradley WE. Fetal isoform of human retinoic acid receptor beta expressed in small cell lung cancer lines Cancer Res 1994;54:365-9.
13. Santner SJ, Dawson PJ, Tait L, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 2001;65:101-10.
14. Peng X, Yun D, Christov K. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids. Int J Oncology 2004;25:961-71.
15. Hayashi K, Goodison S, Urquidi V, et al. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor β isoforms 2 and 4. Int J Oncol 2003;22:623-9.
16. Mehta RR, Bratescu L, Graves JM, et al. Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization. Anticancer Res 1992;12:683-92.
17. Peng X, Maruo T, Matsuo H, Takekida S, Deguchi J. Serum deprivation-induced apoptosis in cultured porcine granulosa cells is characterized by increased expression of p53 protein, Fas antigen and Fas ligand and by decreased expression of PCNA. Endocr J 1998;45:247-53.
18. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987;47:936-42.
19. Kozak M. The scanning model for translation: an update. J Cell Biol 1989;108:229-41.
20. Clifford JL, Menter DG, Wang M, Lotan R, Lippman SM. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells. Cancer Res 1999;59:14-8.
21. Prestridge DS. Predicting Pol II promoter sequence using transcription factor binding sites. J Mol Biol 1995;249:923-32.
22. Knudsen S. Promoter 2.0: for the recognition of PolII promoter sequences. Bioinformatics 1999;15:356-61.
23. Quandt K, Frech K, Karas H, Wingender E, Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995;23:4878-84.
24. Messeguer X, Escudero R, Farré D, Nuñez O. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 2002;18:333-4.
25. Tanaka T, Rodriguez de la Concepcion ML, De Luca LM. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem Pharmacol 2001;61:1347-55.
26. Breathnach R, Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 1981;50:349-83.
27. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (Wash DC) 1996;274:2057-9.
28. Yang Q, Sakurai T, Kakudo K. Retinoic acid receptor β and breast cancer. Breast Cancer Res Treat 2002;76:167-73.
29. Picard E, Seguin C, Monhoven N, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst (Bethesda) 1999;91:1059-66.
30. Kozak M. Effects of long 5′ leader sequences on initiation by eukaryotic ribosomes in vitro. Gene Expr 1991;1:117-25.
31. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 1991;115:887-903.
32. Leroy P, Krust A, Zelent A, et al. Multiple isoforms of the mouse retinoic acid receptor a are generated by alternative splicing and differential induction by retinoic acid. EMBO J 1991;10:59-69.
33. Wei LL, Norris BM, Baker CJ. An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding. J Steroid Biochem Mol Biol 1997;62:287-97.
34. Wei LL, Hawkins P, Baker C, et al. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity. Mol Endocrinol 1996;10:1379-87.
35. Pratt MA, Kralova J, McBurney MW. A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell. Mol Cell Biol 1990;10:6445-53.
36. Durand B, Saunders M, Gaudon C, et al. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 1994;13:5370-82.